120 related articles for article (PubMed ID: 6377215)
1. Evaluation of adverse renal reactions to prolonged indomethacin therapy in preterm infants with persistent ductus arteriosus.
Seyberth HW; Rascher W; Wille L; Hackenthal E; Ulmer HE
Pediatr Pharmacol (New York); 1983; 3(3-4):259-66. PubMed ID: 6377215
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic problems with indomethacin in preterm infants with persistent ductus arteriosus].
Seyberth HW; Müller H; Wille L; Plückthun H; Ulmer HE; Wolf D
Monatsschr Kinderheilkd; 1983 Feb; 131(2):71-6. PubMed ID: 6843560
[TBL] [Abstract][Full Text] [Related]
3. Effect of prolonged indomethacin therapy on renal function and selected vasoactive hormones in very-low-birth-weight infants with symptomatic patent ductus arteriosus.
Seyberth HW; Rascher W; Hackenthal R; Wille L
J Pediatr; 1983 Dec; 103(6):979-84. PubMed ID: 6358443
[TBL] [Abstract][Full Text] [Related]
4. [The significance of renal prostaglandins for kidney function in early childhood].
Seyberth HW
Monatsschr Kinderheilkd; 1987 Apr; 135(4):178-84. PubMed ID: 3600669
[TBL] [Abstract][Full Text] [Related]
5. The effects of indomethacin on renal function and intracranial hemorrhage in infants with patent ductus arteriosus.
Davis JM; Hendricks-Munoz KD; Hagberg D; Manning JA
Dev Pharmacol Ther; 1990; 14(1):15-9. PubMed ID: 2311476
[TBL] [Abstract][Full Text] [Related]
6. The use of dopamine for the prevention of the renal side effects of indomethacin in premature infants with patent ductus arteriosus.
Seri I; Tulassay T; Kiszel J; Csömör S
Int J Pediatr Nephrol; 1984 Dec; 5(4):209-14. PubMed ID: 6397454
[TBL] [Abstract][Full Text] [Related]
7. Effects of ibuprofen and indomethacin on urinary antidiuretic hormone excretion in preterm infants treated for patent ductus arteriosus.
Zanardo V; Vedovato S; Lago P; Piva D; Faggian D; Chiozza L
Fetal Diagn Ther; 2005; 20(6):534-9. PubMed ID: 16260891
[TBL] [Abstract][Full Text] [Related]
8. Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin.
Itabashi K; Ohno T; Nishida H
J Pediatr; 2003 Aug; 143(2):203-7. PubMed ID: 12970633
[TBL] [Abstract][Full Text] [Related]
9. Predicting oliguria following indomethacin for treatment of patent ductus arteriosus.
Barrington KJ; Fox M
Am J Perinatol; 1994 May; 11(3):220-2. PubMed ID: 8048989
[TBL] [Abstract][Full Text] [Related]
10. Comparison of oral ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants.
Fakhraee SH; Badiee Z; Mojtahedzadeh S; Kazemian M; Kelishadi R
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Oct; 9(5):399-403. PubMed ID: 17937843
[TBL] [Abstract][Full Text] [Related]
11. Indomethacin therapy in premature infants with patent ductus arteriosus and oliguria.
Yeh TF; Wilks A; Luken J; Pildes RS
Dev Pharmacol Ther; 1986; 9(6):369-74. PubMed ID: 3816491
[TBL] [Abstract][Full Text] [Related]
12. [Renal effects of prolonged indomethacin therapy in premature infants].
Gouyon JB; Chouchane M; Françoise M
Arch Pediatr; 1994 Oct; 1(10):894-7. PubMed ID: 7842069
[TBL] [Abstract][Full Text] [Related]
13. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
Supapannachart S; Limrungsikul A; Khowsathit P
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
[TBL] [Abstract][Full Text] [Related]
14. Indomethacin therapy in premature infants with patent ductus arteriosus--determination of therapeutic plasma levels.
Yeh TF; Achanti B; Patel H; Pildes RS
Dev Pharmacol Ther; 1989; 12(4):169-78. PubMed ID: 2766920
[TBL] [Abstract][Full Text] [Related]
15. [Indomethacin or ligation in the treatment of persistent ductus arteriosus: a report of clinical experiences].
Sterniste W; Fürnkranz H
Padiatr Padol; 1989; 24(2):153-9. PubMed ID: 2762001
[TBL] [Abstract][Full Text] [Related]
16. Recovery of prostaglandin production associated with reopening of the ductus arteriosus after indomethacin treatment in preterm infants with respiratory distress syndrome.
Seyberth HW; Müller H; Wille L; Plückthun H; Wolf D; Ulmer HE
Pediatr Pharmacol (New York); 1982; 2(2):127-41. PubMed ID: 12760405
[TBL] [Abstract][Full Text] [Related]
17. Indomethacin and its effect on renal function and urinary kallikrein excretion in premature infants with patent ductus arteriosus.
Betkerur MV; Yeh TF; Miller K; Glasser RJ; Pildes RS
Pediatrics; 1981 Jul; 68(1):99-102. PubMed ID: 6909683
[TBL] [Abstract][Full Text] [Related]
18. Urinary aquaporin-2 excretion during ibuprofen or indomethacin treatment in preterm infants with patent ductus arteriosus.
Li Y; Zelenina M; Plat-Willson G; Marcoux MO; Aperia A; Casper C
Acta Paediatr; 2011 Jan; 100(1):59-66. PubMed ID: 21143292
[TBL] [Abstract][Full Text] [Related]
19. Furosemide does not prevent indomethacin-induced renal side effects in preterm infants.
Romagnoli C; Zecca E; Papacci P; De Carolis MP; Giannini R; Gallini F; Tortorolo G
Clin Pharmacol Ther; 1997 Aug; 62(2):181-6. PubMed ID: 9284854
[TBL] [Abstract][Full Text] [Related]
20. Intravenous indomethacin and changes of renal function in premature infants with patent ductus arteriosus.
John EG; Vasan U; Hastreiter AR; Bhat R; Evans MA
Pediatr Pharmacol (New York); 1984; 4(1):11-9. PubMed ID: 6739182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
